4132 Stock Overview
Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Golden Biotechnology Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$29.30 |
| 52 Week High | NT$71.40 |
| 52 Week Low | NT$27.55 |
| Beta | 0.84 |
| 1 Month Change | -11.35% |
| 3 Month Change | -17.58% |
| 1 Year Change | -52.12% |
| 3 Year Change | -44.51% |
| 5 Year Change | -25.08% |
| Change since IPO | -20.81% |
Recent News & Updates
Shareholder Returns
| 4132 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | 4.8% | -0.7% | -1.6% |
| 1Y | -52.1% | -23.7% | 25.9% |
Return vs Industry: 4132 underperformed the TW Biotechs industry which returned -23.7% over the past year.
Return vs Market: 4132 underperformed the TW Market which returned 25.9% over the past year.
Price Volatility
| 4132 volatility | |
|---|---|
| 4132 Average Weekly Movement | 7.1% |
| Biotechs Industry Average Movement | 4.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.6% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 4132's share price has been volatile over the past 3 months.
Volatility Over Time: 4132's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | Li Yu Wu | www.goldenbiotech.com.tw |
Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore. Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males. The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia.
Golden Biotechnology Corporation Fundamentals Summary
| 4132 fundamental statistics | |
|---|---|
| Market cap | NT$4.17b |
| Earnings (TTM) | -NT$207.24m |
| Revenue (TTM) | NT$185.79m |
22.4x
P/S Ratio-20.1x
P/E RatioIs 4132 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4132 income statement (TTM) | |
|---|---|
| Revenue | NT$185.79m |
| Cost of Revenue | NT$41.09m |
| Gross Profit | NT$144.70m |
| Other Expenses | NT$351.94m |
| Earnings | -NT$207.24m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.46 |
| Gross Margin | 77.88% |
| Net Profit Margin | -111.55% |
| Debt/Equity Ratio | 41.0% |
How did 4132 perform over the long term?
See historical performance and comparison